Here, we report a case of EDKA in a type 2 diabetic patient who recently changed his diabetes medications and started on GLP1 receptor agonists (dulaglutide) along with metformin, gliclazide, and empagliflozin. Here, GLP1R is linked to diabetes mellitus.